Neogen(NASDAQ) NEOG

Current Price$9.81

Market Cap$2.16B

Since IPO (1992)+3,786%

5 Year-77%

1 Year+108%

1 Month+7%

Neogen last closing stock price
Metric	Price	Date
Last close	USD 9.93	2026-07-21

Neogen stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+2.69%	USD 9.67	2026-07-14
1 month	+6.66%	USD 9.31	2026-06-18
3 month	+4.31%	USD 9.52	2026-04-22
Year to date	+42.06%	USD 6.99	2025-12-31
1 year	+107.74%	USD 4.78	2025-07-21
3 year	-55.98%	USD 22.56	2023-07-21
5 year	-76.79%	USD 42.79	2021-07-22
Since inception	+3,785.58%	USD 0.26	1992-05-01

Neogen Financials at a Glance

Market Cap

$2.16B

Revenue (TTM)

$870.54M

Net Income (TTM)

-$608.78M

EPS (TTM)

-$2.80

P/E Ratio

-3.54

Dividend

$0.00

Beta (Volatility)

0.78 (Low)

Dividend

$0.00

Beta (Volatility)

0.78 (Low)

Price

$9.81

Volume

470,103.463

Open

$9.86

Price

$9.81

Volume

470,103.463

Open

$9.86

Previous Close

$9.93

Daily Range

$9.78 - $9.97

52-Week Range

$4.56 - $11.43

Estimated Earnings Date

Jul 30, 2026

Dividend

$0.00

Beta (Volatility)

0.78 (Low)

Price

$9.81

Volume

470,103.463

Open

$9.86

Previous Close

$9.93

Daily Range

$9.78 - $9.97

52-Week Range

$4.56 - $11.43

Estimated Earnings Date

Jul 30, 2026

NEOG News

Dog looking at camera with its mouth open

What to Expect from Neogen

Seth JaysonJul 19, 2013

Neogen Acquires Veterinary Instrument Business

Rich DupreyJul 1, 2013

How Fast Is the Cash at Neogen?

Seth JaysonJun 24, 2013

Page 1

NEOG: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Neogen

Neogen helps keep food and animals safe from harmful germs.

The company makes kits that test for hidden food dangers.

It serves farmers, food factories, and veterinarians.

What Does Neogen Do?

Food Safety: Diagnostic test kits that find bacteria, toxins, and allergens in food; generated $156.7 million in revenue for Q3 2026.
Animal Safety: Veterinary tools, medicines, and vaccines used by farmers to care for livestock; generated $54.5 million in revenue for Q3 2026.
Genomics Services: DNA testing that helps breeders and pet owners understand animal genetics and health.

Reshaping the Business

Sold the Cleaners and Disinfectants business to Kersia Group for $121.7 million in fiscal 2026.
Agreed to sell the genomics business to Zoetis Inc. for $160 million in March 2026.
Integrated the 3M Food Safety business to expand diagnostic testing tools for global food producers.
Relocated sample collection product manufacturing into internal facilities to streamline production.

Standing Out in Safety

Neogen maintains a global network serving veterinarians and food processors. Its focus on essential safety testing provides a specialized niche in healthcare and agriculture. The company emphasizes internal manufacturing to improve production efficiency.

The Financial Scorecard

Total revenue was $211.2 million in Q3 2026, down 4.4% from $221 million in Q3 2025.
Operating loss reached $3.3 million in Q3 2026, worsening from a $5.4 million profit in Q3 2025.
Net loss deepened to $17 million in Q3 2026, compared to a $10.9 million loss in Q3 2025.
Operating cash flow reached $53 million for the nine months ended February 28, 2026, up from $41.8 million.

The Path Forward

Neogen is streamlining its operations to focus on core safety testing products. This shift follows major acquisitions and significant portfolio changes.

AI Generated • May 26, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

2,974

CEO

Mikhael Nassif

Website

www.neogen.com

Headquarters

Lansing, MI 48912, US

NEOG Financials

Key Financial Metrics (TTM)

Gross Margin

42.56%

Operating Margin

-4.36%

Net Income Margin

-69.93%

Return on Equity

-29.00%

Return on Capital

0.32%

Return on Assets

-18.12%

Earnings Yield

-28.25%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.16B

Shares Outstanding

217.67M

Volume

470.10K

Avg. Volume

2.25M

Financials (TTM)

Gross Profit

$370.51M

Operating Income

-$37.91M

EBITDA

-$448.60M

Operating Cash Flow

$69.54M

Capital Expenditure

-$27.77M

Free Cash Flow

$41.78M

Cash & ST Invst.

$159.90M

Total Debt

$793.30M

Neogen Performance Analysis

Neogen annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-05-31	USD 527,159,000	N/A
2023	2023-05-31	USD 822,447,000	56.0%
2024	2024-05-31	USD 924,222,000	12.4%
2025	2025-05-31	USD 894,661,000	-3.2%

Neogen sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2025-05-31	2.0%
Q1	2025-08-31	-7.2%
Q2	2025-11-30	7.4%
Q3	2026-02-28	-6.0%

Neogen annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-05-31	USD 0.45	N/A
2023	2023-05-31	USD -0.12	N/A
2024	2024-05-31	USD -0.04	-64.1%
2025	2025-05-31	USD -5.03	11474.5%

Neogen sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2025-05-31	-5484.2%
Q1	2025-08-31	106.0%
Q2	2025-11-30	-143.1%
Q3	2026-02-28	-9.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$211.20M

-4.4%

Gross Profit

$99.00M

+13.8%

Gross Margin

46.88%

N/A

Market Cap

$2.16B

N/A

Market Cap/Employee

$726.80K

N/A

Employees

2,974

N/A

Net Income

-$17.00M

-55.2%

EBITDA

$22.50M

-39.8%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Total Cash

$159.90M

+25.2%

Total Debt

$793.30M

-11.2%

Accounts Receivable

$137.10M

-14.3%

Inventory

$161.70M

-21.3%

Long Term Debt

$793.30M

-10.9%

Short Term Debt

$0.00

-100.0%

Return on Assets

-18.12%

N/A

Return on Invested Capital

-1.18%

N/A

Free Cash Flow

$11.07M

+182.0%

Operating Cash Flow

$22.70M

+17.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NVCRNovocure Ltd

NVCRNovocure Ltd$15.24-4.78%

BLFSBioLife Solutions, Inc.

BLFSBioLife Solutions, Inc.$31.26+7.07%

ZBIOZenas BioPharma, Inc.

ZBIOZenas BioPharma, Inc.$31.67-2.13%

CNMDCONMED Corporation

CNMDCONMED Corporation$41.64-0.57%

KMTSKestra Medical Technologies, Ltd.

KMTSKestra Medical Technologies, Ltd.$21.27-4.35%

NTLAIntellia Therapeutics, Inc.

NTLAIntellia Therapeutics, Inc.$11.11-3.18%

AZTAAzenta, Inc.

AZTAAzenta, Inc.$26.87+1.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$15.21-0.00%

FFord Motor Company

FFord Motor Company$14.42+0.01%

TET1 Energy Inc.

TET1 Energy Inc.$6.08-0.00%

MARAMara Holdings

MARAMara Holdings$12.48+0.02%

JOBYJoby Aviation

JOBYJoby Aviation$7.67+0.00%

RIGTransocean

RIGTransocean$5.31+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.59+0.01%

Questions About NEOG

What is the current price of Neogen?

Neogen is trading at $9.80 per share.

What is the 52-week range for Neogen?

Over the past 52 weeks, Neogen has traded between $4.56 and $11.43.

How much debt does Neogen have?

As of the most recent reporting period, Neogen reported total debt of $793.30M.

How much cash does Neogen have on hand?

Neogen reported $159.90M in cash and cash equivalents in its most recent financial results.

What is Neogen’s dividend yield?

Neogen does not currently have a dividend yield.

Neogen(NASDAQ) NEOG

Neogen Financials at a Glance

NEOG News

Why Neogen Stock Blasted More Than 31% Higher Today

Why Shares of Neogen Are Slumping This Week

3 Recession-Ready Stocks to Buy Right Now

Why CenturyLink, Jabil, and Neogen Slumped Today

5 Ways to Invest in the Growing Pet Industry

What to Expect from Neogen

Neogen Acquires Veterinary Instrument Business

How Fast Is the Cash at Neogen?

NEOG: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Neogen

What Does Neogen Do?

Reshaping the Business

Standing Out in Safety

The Financial Scorecard

The Path Forward

NEOG Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Neogen Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NEOG

What is the current price of Neogen?

What is the 52-week range for Neogen?

How much debt does Neogen have?

How much cash does Neogen have on hand?

What is Neogen’s dividend yield?

Premium Investing Services